Clinical trial Recruiting at 1 site Observational Ages 18 and up

Survey to determine eligibility for cardiovascular and obesity clinical trials

Official title: Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility (SWIFT-CORE-101)

Run by Brooklyn Clinical Research · NCT06412536 · Data updated 2026-11-12

This study is trying to see if people with heart issues or obesity can join new clinical trials by having them fill out a survey and undergo some health checks.

More Obesity trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment10000 (estimated)
SponsorBrooklyn Clinical Research
Research network
Locations1 site (Brooklyn, New York)
StatusRecruiting
StartedMay 30, 2024
Main results expectedApril 10, 2029
Study endsApril 17, 2029
Registry record updatedJune 11, 2024
Trial IDNCT06412536 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who are interested in participating in clinical trials for cardiovascular diseases and obesity-related conditions.

Probably not a fit

Patients who are pregnant, breastfeeding, or have significant health issues that could affect their safety or study results may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the eligibility of potential participants for industry-sponsored clinical trials focused on cardiovascular diseases, obesity, and related endocrine conditions. Participants will undergo a survey that includes demographic information, medical history, and current symptoms, overseen by a physician. Vital signs, urine drug screens, blood draws, and urine pregnancy tests may also be collected to evaluate suitability for participation. The physician will conduct a clinical interview and may consult with the participant's current healthcare providers to confirm eligibility.

Why it matters

Potential benefit: If successful, this study could streamline the process of identifying eligible patients for clinical trials, potentially leading to improved treatment options for cardiovascular and metabolic conditions.

How similar studies have gone: While this approach is observational and focused on eligibility assessment, similar studies have successfully identified participants for clinical trials in related fields.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
2. Participant is at least 18 years old.

Exclusion Criteria:

1. Participant is pregnant, breast-feeding, or planning to become pregnant.
2. History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
3. Moderate or severe substance use disorder within 90 days prior to screen
4. Any condition that in the investigator's opinion makes a participant unsuitable for the study.
5. Currently employed by Swift Clinical Research Group, Inc. or any of its subsidiaries, including Brooklyn Clinical Research, or a first-degree relative of an employee.

Where it's running

  • Brooklyn Clinical Research
    Brooklyn, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.